Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

September 17, 2022

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

Outpatient Management of Acute PE Remains Underused

Top Endovascular News of 2023

FDA Approves Paradise Renal Denervation System: What Comes Next?

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

TCTMD’s Top 10 Most Popular Stories for October 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

FLASH: More Data to Support Mechanical Thrombectomy in PE

Have We Gotten to the Final Word on Paclitaxel Safety?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content